Properties of cancer stem cells

Adult stem cells (ASCs) are pluripotent and make up a small percentage of healthy tissue. ASCs are essential for tissue repair, regeneration and growth. ASCs divide into identical stem cells or transiently proliferating cells. The latter cells mature after a number of divisions and become adult differentiating cells. There are different types of cells in cancerous tissue, as in normal, healthy tissue. Most cancer tissues contain three types of cells: (I) cancer stem cells (CSC); (II) cancer initiating cells; and (III) “differentiated”, non-proliferating cancer cells. In the review, the authors present experimental evidences for the presence of CSC, describe cell surface and intracellular markers of CSC. These markers allow for the appropriate identification and isolation of CSC. In addition, the possible location of these cells and theories of their formation are considered. It should be noted, that the theories of CSC originating are in fact theories of neoplasm formation. Many factors and processes may be involved in the formation of CSC. These include: (I) mutations of oncogenes or tumor suppressor genes in spoczynadult differentiated cells; (II) expression of different regulatory RNA types (microRNAs or long non-coding RNAs); processes of epithelial-mesenchymal transition and mesenchymalepithelial transition; (IV) CSC formation from differentiated cancer cells in a consequence of cancer therapy; (V) formation of CSC in conditions of hypoxy and during cell aging. The presented work synthetically characterizes the features, localization and formation of cancer stem cells. Furthermore, the research on these cells is still ongoing and many properties of CSC have not been fully understood.

[1]  M. Mezei,et al.  An NR2F1-specific agonist suppresses metastasis by inducing cancer cell dormancy , 2021, The Journal of experimental medicine.

[2]  D. Salomon,et al.  Whence CRIPTO: The Reemergence of an Oncofetal Factor in ‘Wounds’ That Fail to Heal , 2021, International journal of molecular sciences.

[3]  A. Schambach,et al.  A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML , 2021, International journal of molecular sciences.

[4]  N. Park,et al.  DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma. , 2021, Experimental cell research.

[5]  T. Kurokawa,et al.  Rapid reprogramming of tumour cells into cancer stem cells on double-network hydrogels , 2021, Nature Biomedical Engineering.

[6]  Sangkyu Park,et al.  Applications of Mesenchymal Stem Cells in Skin Regeneration and Rejuvenation , 2021, International journal of molecular sciences.

[7]  Pourya Naderi Yeganeh,et al.  Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown , 2021, Proceedings of the National Academy of Sciences.

[8]  J. Ajani,et al.  Drug resistance and Cancer stem cells , 2021, Cell Communication and Signaling.

[9]  Erika Hooker,et al.  COCO/DAND5 inhibits developmental and pathological ocular angiogenesis , 2021, EMBO molecular medicine.

[10]  M. Fakih,et al.  Targeting KRAS in Colorectal Cancer , 2021, Current Oncology Reports.

[11]  A. Angius,et al.  Portrait of Cancer Stem Cells on Colorectal Cancer: Molecular Biomarkers, Signaling Pathways and miRNAome , 2021, International journal of molecular sciences.

[12]  S. Pauklin,et al.  3D chromatin architecture and epigenetic regulation in cancer stem cells , 2021, Protein & Cell.

[13]  M. Obonyo,et al.  Early detection of tumor cells in bone marrow and peripheral blood in a fast-progressing gastric cancer model , 2021, International journal of oncology.

[14]  A. Khamidullina,et al.  Snail-Family Proteins: Role in Carcinogenesis and Prospects for Antitumor Therapy , 2021, Acta naturae.

[15]  E. Adriaenssens,et al.  Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19 , 2020, Cells.

[16]  R. Jove,et al.  Differences and similarities between cancer and somatic stem cells: therapeutic implications , 2020, Stem cell research & therapy.

[17]  Z. Fasoulakis,et al.  Role of Oncogenes and Tumor-suppressor Genes in Carcinogenesis: A Review , 2020, AntiCancer Research.

[18]  B. Bruneau,et al.  Regulation of single-cell genome organization into TADs and chromatin nanodomains , 2020, Nature Genetics.

[19]  Ping-Hui Tseng,et al.  The Role of Smoothened in Cancer , 2020, International journal of molecular sciences.

[20]  T. Yevsa,et al.  Cancer Stem Cells—Origins and Biomarkers: Perspectives for Targeted Personalized Therapies , 2020, Frontiers in Immunology.

[21]  T. Mitsiadis,et al.  Cancer Stem Cells, Quo Vadis? The Notch Signaling Pathway in Tumor Initiation and Progression , 2020, Cells.

[22]  I. Bellantuono,et al.  Senescence and Cancer: A Review of Clinical Implications of Senescence and Senotherapies , 2020, Cancers.

[23]  Lihua Song,et al.  SUV39H1-Mediated DNMT1 is Participated in the Epigenetic Regulation of Smad3 in Cervical Cancer. , 2020, Anti-cancer agents in medicinal chemistry.

[24]  Marzieh Ebrahimi,et al.  An integrated analysis to predict micro‐RNAs targeting both stemness and metastasis in human gastric cancer , 2020, Journal of gastroenterology and hepatology.

[25]  W. Jiang,et al.  Noggin is associated with a poor prognosis of gastric cancer by promoting the proliferation of gastric cancer cells via the upregulation of EGFR. , 2020, International Journal of Oncology.

[26]  M. Seno,et al.  Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments , 2020, Cells.

[27]  A. Maiorana,et al.  CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells? , 2020, Oncotarget.

[28]  M. Loza,et al.  Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy , 2020, Cells.

[29]  Yiyan Lei,et al.  HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling , 2020, Theranostics.

[30]  A. Budovsky,et al.  A Multidimensional Systems Biology Analysis of Cellular Senescence in Ageing and Disease , 2019, bioRxiv.

[31]  Y. Xuan,et al.  LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma. , 2019, Experimental and molecular pathology.

[32]  Aristotelis Tsirigos,et al.  KLF4 is involved in the organization and regulation of pluripotency-associated three-dimensional enhancer networks , 2019, Nature Cell Biology.

[33]  A. Giatromanolaki,et al.  'Stemness' and 'senescence' related escape pathways are dose dependent in lung cancer cells surviving post irradiation. , 2019, Life sciences.

[34]  Wenjie Zhu,et al.  Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma , 2019, BMC Cancer.

[35]  Ke-Chih Lin,et al.  Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance , 2019, The Prostate.

[36]  Bandana Sharma,et al.  BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells , 2019, Nature.

[37]  Y. Xuan,et al.  LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma. , 2019, Pathology, research and practice.

[38]  Min Zhao,et al.  Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis. , 2019, Cancer letters.

[39]  P. Circosta,et al.  Chronic myeloid leukemia stem cells , 2019, Leukemia.

[40]  N. Miyoshi,et al.  Oct4 Gene Expression in Primary Colorectal Cancer Promotes Liver Metastasis , 2019, Stem cells international.

[41]  R. Weinberg,et al.  Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells , 2019, Proceedings of the National Academy of Sciences.

[42]  C. Blanpain,et al.  EMT Transition States during Tumor Progression and Metastasis. , 2019, Trends in cell biology.

[43]  W. Ding,et al.  Metastasis-associated protein 1 (MTA1) is transferred by exosomes and contributes to the regulation of hypoxia and estrogen signaling in breast cancer cells , 2019, Cell Communication and Signaling.

[44]  Jie Li,et al.  Increased musashi 2 expression indicates a poor prognosis and promotes malignant phenotypes in gastric cancer , 2019, Oncology letters.

[45]  J. Rich,et al.  Cancer Stem Cells: The Architects of the Tumor Ecosystem. , 2019, Cell stem cell.

[46]  Shou-Ching Tang,et al.  H19 regulation of oestrogen induction of symmetric division is achieved by antagonizing Let‐7c in breast cancer stem‐like cells , 2018, Cell proliferation.

[47]  J. Kessler,et al.  BMP-dependent, injury-induced stem cell niche as a mechanism of heterotopic ossification , 2019, Stem Cell Research & Therapy.

[48]  Young Kee Shin,et al.  Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview , 2018, Cellular Physiology and Biochemistry.

[49]  J. Utikal,et al.  Targeting SOX2 in anticancer therapy , 2018, Expert opinion on therapeutic targets.

[50]  M. Hoque,et al.  CD24 regulates cancer stem cell (CSC)-like traits and a panel of CSC-related molecules serves as a non-invasive urinary biomarker for the detection of bladder cancer , 2018, British Journal of Cancer.

[51]  Robert C. G. Martin,et al.  Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma , 2018, BMC Cancer.

[52]  B. Yahaya,et al.  Novel triple-positive markers identified in human non-small cell lung cancer cell line with chemotherapy-resistant and putative cancer stem cell characteristics , 2018, Oncology reports.

[53]  Stefan Enroth,et al.  Genomewide binding of transcription factor Snail1 in triple‐negative breast cancer cells , 2018, Molecular oncology.

[54]  J. Jassem,et al.  MiR-192 and miR-662 enhance chemoresistance and invasiveness of squamous cell lung carcinoma. , 2018, Lung cancer.

[55]  Jiqian Xu,et al.  Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer , 2018, Cellular Physiology and Biochemistry.

[56]  D. Prabavathy,et al.  Lung cancer stem cells-origin, characteristics and therapy. , 2018, Stem cell investigation.

[57]  Jonathan M. Cairns,et al.  Long-Range Enhancer Interactions Are Prevalent in Mouse Embryonic Stem Cells and Are Reorganized upon Pluripotent State Transition , 2018, Cell reports.

[58]  R. Young,et al.  Regulation and Dysregulation of Chromosome Structure in Cancer , 2018 .

[59]  M. Rosenfeldt,et al.  Autophagy and cancer – insights from mouse models , 2018, The FEBS journal.

[60]  H. Yao,et al.  CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness , 2018, Cell.

[61]  S. K. Hemalatha,et al.  Proteomic Profiling of β-hCG-Induced Spheres in BRCA1 Defective Triple Negative Breast Cancer Cells. , 2018, Journal of proteome research.

[62]  B. Kamińska,et al.  Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features , 2018, Cancer biology & therapy.

[63]  F. Peng,et al.  Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia , 2017, Oncogene.

[64]  S. Capitani,et al.  Up-modulation of PLC-β2 reduces the number and malignancy of triple-negative breast tumor cells with a CD133+/EpCAM+ phenotype: a promising target for preventing progression of TNBC , 2017, BMC Cancer.

[65]  H. Kung,et al.  Long non-coding RNA and tumor hypoxia: new players ushered toward an old arena , 2017, Journal of Biomedical Science.

[66]  Ling-Ling Chen,et al.  The Diversity of Long Noncoding RNAs and Their Generation. , 2017, Trends in genetics : TIG.

[67]  T. Tian,et al.  Linc-ROR induces epithelial-to-mesenchymal transition in ovarian cancer by increasing Wnt/β-catenin signaling , 2017, Oncotarget.

[68]  Y. Yen,et al.  Long noncoding RNA LncHIFCAR/MIR31HG is a HIF-1α co-activator driving oral cancer progression , 2017, Nature Communications.

[69]  X. Zhong,et al.  CD49f Can Act as a Biomarker for Local or Distant Recurrence in Breast Cancer , 2017, Journal of breast cancer.

[70]  Shinya Sugimoto,et al.  Visualization and targeting of LGR5+ human colon cancer stem cells , 2017, Nature.

[71]  Liang Xu,et al.  Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer , 2017, Cell cycle.

[72]  J. Xiong,et al.  Uncovering the roles of long non-coding RNAs in cancer stem cells , 2017, Journal of Hematology & Oncology.

[73]  T. Wang,et al.  The Origins of Gastric Cancer From Gastric Stem Cells: Lessons From Mouse Models , 2017, Cellular and molecular gastroenterology and hepatology.

[74]  Ana Helena Santos,et al.  Molecular characterization of CD44+/CD24−/Ck+/CD45− cells in benign and malignant breast lesions , 2017, Virchows Archiv.

[75]  Rongxia Liao,et al.  Induced cancer stem cells generated by radiochemotherapy and their therapeutic implications , 2016, Oncotarget.

[76]  A. Miyajima,et al.  Y-box binding protein-1 promotes hepatocellular carcinoma-initiating cell progression and tumorigenesis via Wnt/β-catenin pathway , 2016, Oncotarget.

[77]  S. Kaneko,et al.  The evolving concept of liver cancer stem cells , 2017, Molecular Cancer.

[78]  T. Nakajima,et al.  Distribution of Lgr5‐positive cancer cells in intramucosal gastric signet‐ring cell carcinoma , 2016, Pathology international.

[79]  S. Sen,et al.  Characterization of cancer stem cells from different grades of human colorectal cancer , 2016, Tumor Biology.

[80]  Jacques Haiech,et al.  Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy , 2016, Stem cells international.

[81]  Yan-Ze Jin,et al.  Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma , 2016, Oncotarget.

[82]  Limei Liu,et al.  IGF/STAT3/NANOG/Slug Signaling Axis Simultaneously Controls Epithelial‐Mesenchymal Transition and Stemness Maintenance in Colorectal Cancer , 2016, Stem cells.

[83]  J. Utikal,et al.  Directed Dedifferentiation Using Partial Reprogramming Induces Invasive Phenotype in Melanoma Cells , 2016, Stem cells.

[84]  Wenbo Tang,et al.  MicroRNA-421 regulated by HIF-1α promotes metastasis, inhibits apoptosis, and induces cisplatin resistance by targeting E-cadherin and caspase-3 in gastric cancer , 2016, Oncotarget.

[85]  D. Candinas,et al.  R‐spondin 1 and noggin facilitate expansion of resident stem cells from non‐damaged gallbladders , 2016, EMBO reports.

[86]  R. Friesel,et al.  Sef Regulates Epithelial‐Mesenchymal Transition in Breast Cancer Cells , 2016, Journal of cellular biochemistry.

[87]  S. Cheung,et al.  Hepatic cancer stem cell marker granulin-epithelin precursor and β-catenin expression associate with recurrence in hepatocellular carcinoma , 2016, Oncotarget.

[88]  Ximing Xu,et al.  Twist mediates an aggressive phenotype in human colorectal cancer cells. , 2016, International journal of oncology.

[89]  Min Chen,et al.  Role of CD44high/CD133high HCT-116 cells in the tumorigenesis of colon cancer , 2016, Oncotarget.

[90]  K. Nan,et al.  Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study , 2016, Oncotarget.

[91]  Kaori Tanaka,et al.  Aldehyde dehydrogenase 1A1 in stem cells and cancer , 2016, Oncotarget.

[92]  D. Geller,et al.  Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells , 2015, Oncotarget.

[93]  M. Esteller,et al.  MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b , 2015, Oncotarget.

[94]  Shoumei Bai,et al.  Identifying an ovarian cancer cell hierarchy regulated by bone morphogenetic protein 2 , 2015, Proceedings of the National Academy of Sciences.

[95]  W. Krol,et al.  Prostate Cancer Stem Cells: Research Advances , 2015, International journal of molecular sciences.

[96]  Gary K. Schwartz,et al.  Tumour exosome integrins determine organotropic metastasis , 2015, Nature.

[97]  Hu Pu,et al.  CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc , 2015, Oncotarget.

[98]  Hailin Tang,et al.  LGR5 Promotes Breast Cancer Progression and Maintains Stem‐Like Cells Through Activation of Wnt/β‐Catenin Signaling , 2015, Stem cells.

[99]  Dong-mei Zhao,et al.  Cooperatively transcriptional and epigenetic regulation of sonic hedgehog overexpression drives malignant potential of breast cancer , 2015, Cancer science.

[100]  D. Wei,et al.  Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target , 2015, Stem cells translational medicine.

[101]  T. Ochiya,et al.  Identification and Characterization of CXCR4-Positive Gastric Cancer Stem Cells , 2015, PloS one.

[102]  Runsheng Chen,et al.  The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. , 2015, Cell stem cell.

[103]  Antonella Galli,et al.  Activin/Nodal signaling and NANOG orchestrate human embryonic stem cell fate decisions by controlling the H3K4me3 chromatin mark , 2015, Genes & development.

[104]  D. Fan,et al.  The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links. , 2015, Current pharmaceutical design.

[105]  S. Ferrini,et al.  CD133-Positive Cells from Non-Small Cell Lung Cancer Show Distinct Sensitivity to Cisplatin and Afatinib , 2015, Archivum Immunologiae et Therapiae Experimentalis.

[106]  N. Socci,et al.  MDM2 turnover and expression of ATRX determine the choice between quiescence and senescence in response to CDK4 inhibition , 2015, Oncotarget.

[107]  Fabian J Theis,et al.  Stem-cell-like properties and epithelial plasticity arise as stable traits after transient Twist1 activation. , 2015, Cell reports.

[108]  Yanjun Zeng,et al.  Hypothermia Stimulates Glioma Stem Spheres to Spontaneously Dedifferentiate Adjacent Non-stem Glioma Cells , 2015, Cellular and Molecular Neurobiology.

[109]  Yong Han,et al.  miR‐99a directly targets the mTOR signalling pathway in breast cancer side population cells , 2014, Cell proliferation.

[110]  George A Calin,et al.  Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. , 2014, Cancer cell.

[111]  Qiulian Wu,et al.  Glioma cancer stem cells secrete Gremlin1 to promote their maintenance within the tumor hierarchy , 2014, Genes & development.

[112]  Y. Nie,et al.  Gastric cancer stem cells in gastric carcinogenesis, progression, prevention and treatment. , 2014, World journal of gastroenterology.

[113]  A. Krešo,et al.  Evolution of the cancer stem cell model. , 2014, Cell stem cell.

[114]  Ziping Zhang,et al.  Cloning, characterization, hypoxia and heat shock response of hypoxia inducible factor-1 (HIF-1) from the small abalone Haliotis diversicolor. , 2014, Gene.

[115]  S. Morrison,et al.  The bone marrow niche for haematopoietic stem cells , 2014, Nature.

[116]  Fan Yang,et al.  Reciprocal regulation of HIF-1α and lincRNA-p21 modulates the Warburg effect. , 2014, Molecular cell.

[117]  Ming Yu,et al.  Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation , 2013, Genes & development.

[118]  Yuepeng Zhou,et al.  Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells , 2013, Cancer Cell International.

[119]  X. Bian,et al.  Identification of CD90 as a marker for lung cancer stem cells in A549 and H446 cell lines. , 2013, Oncology reports.

[120]  Cheng-Wen Wu,et al.  The Emerging Role of SOX2 in Cell Proliferation and Survival and Its Crosstalk with Oncogenic Signaling in Lung Cancer , 2013, Stem cells.

[121]  J. McQualter,et al.  TGF-β signaling in stromal cells acts upstream of FGF-10 to regulate epithelial stem cell growth in the adult lung. , 2013, Stem cell research.

[122]  B. Zhou,et al.  The Role of Snail in EMT and Tumorigenesis. , 2013, Current cancer drug targets.

[123]  B. Wang,et al.  Generation of Breast Cancer Stem Cells by Steroid Hormones in Irradiated Human Mammary Cell Lines , 2013, PloS one.

[124]  Andrew E. Sloan,et al.  Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake , 2013, Nature Neuroscience.

[125]  W. Bamlet,et al.  SOX2 promotes dedifferentiation and imparts stem cell-like features to pancreatic cancer cells , 2013, Oncogenesis.

[126]  I. Sánchez-García,et al.  Function of oncogenes in cancer development: a changing paradigm , 2013, The EMBO journal.

[127]  Xinghuan Wang,et al.  Enrichment of Prostate Cancer Stem-Like Cells from Human Prostate Cancer Cell Lines by Culture in Serum-Free Medium and Chemoradiotherapy , 2013, International journal of biological sciences.

[128]  R. Sridharan,et al.  The nexus of Tet1 and the pluripotency network. , 2013, Cell stem cell.

[129]  E. Cuyás,et al.  The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells , 2013, Cell cycle.

[130]  David A. Orlando,et al.  Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers , 2013, Cell.

[131]  P. Pelicci,et al.  DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions , 2013, Proceedings of the National Academy of Sciences.

[132]  Kirsten R. McEwen,et al.  Naïve pluripotency is associated with global DNA hypomethylation , 2013, Nature Structural &Molecular Biology.

[133]  C. Dubois,et al.  Skin squamous cell carcinoma propagating cells increase with tumour progression and invasiveness , 2012, The EMBO journal.

[134]  Yanlei Li,et al.  Characterization of sphere-forming cells with stem-like properties from the small cell lung cancer cell line H446. , 2012, Cancer letters.

[135]  M. Chapellier,et al.  [BMP and cancer: the Yin and Yang of stem cells]. , 2012, Medecine sciences : M/S.

[136]  Elisa Laurenti,et al.  Hematopoiesis: a human perspective. , 2012, Cell stem cell.

[137]  P. Gimotty,et al.  Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation , 2012, Oncogene.

[138]  Lei Ding,et al.  Endothelial and perivascular cells maintain haematopoietic stem cells , 2011, Nature.

[139]  M. Watabe,et al.  Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone , 2011, The Journal of experimental medicine.

[140]  X. Chen,et al.  Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells. , 2011, Gastroenterology.

[141]  M. Greaves Cancer stem cells renew their impact , 2011, Nature Medicine.

[142]  R. Jandial,et al.  Cancer stem cells can arise from differentiated neoplastic cells. , 2011, Neurosurgery.

[143]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[144]  A. Iwama,et al.  Bmi1 is essential for leukemic reprogramming of myeloid progenitor cells , 2011, Leukemia.

[145]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[146]  K. Struhl,et al.  Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion , 2011, Proceedings of the National Academy of Sciences.

[147]  J. Rinn,et al.  Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells , 2010, Nature Genetics.

[148]  P. Flicek,et al.  Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. , 2010, Molecular cell.

[149]  R. McLendon,et al.  Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.

[150]  G. Pelosi,et al.  Alterations of the Notch pathway in lung cancer , 2009, Proceedings of the National Academy of Sciences.

[151]  Seo-Hee Kim,et al.  CD24 overexpression in cancer development and progression: a meta-analysis. , 2009, Oncology reports.

[152]  Kairong Cui,et al.  H3.3/H2A.Z double variant-containing nucleosomes mark ‘nucleosome-free regions’ of active promoters and other regulatory regions in the human genome , 2009, Nature Genetics.

[153]  Tannishtha Reya,et al.  Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia , 2009, Nature.

[154]  X. Wang,et al.  EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. , 2009, Gastroenterology.

[155]  Angela C. Colmone,et al.  Leukemic Cells Create Bone Marrow Niches That Disrupt the Behavior of Normal Hematopoietic Progenitor Cells , 2008, Science.

[156]  J. Visvader,et al.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.

[157]  Robert A. Weinberg,et al.  Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. , 2008, Developmental cell.

[158]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[159]  Z. Werb,et al.  GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model. , 2008, Cancer cell.

[160]  J. Lieberman,et al.  let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.

[161]  Mina J. Bissell,et al.  Evidence for a stem cell hierarchy in the adult human breast , 2007, The Journal of cell biology.

[162]  Kelly M. McGarvey,et al.  A stem cell–like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing , 2007, Nature Genetics.

[163]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[164]  D. Scadden,et al.  The hematopoietic stem cell in its place , 2006, Nature Immunology.

[165]  Katarzyna Wilk,et al.  Potential structural role of non-coding and coding RNAs in the organization of the cytoskeleton at the vegetal cortex of Xenopus oocytes , 2005, Development.

[166]  S. Morrison,et al.  Supplemental Experimental Procedures , 2022 .

[167]  R. Henkelman,et al.  Identification of human brain tumour initiating cells , 2004, Nature.

[168]  S. Lowe,et al.  Intrinsic tumour suppression , 2004, Nature.

[169]  D. Guernsey,et al.  Neosis: A Novel Type of Cell Division in Cancer , 2004, Cancer biology & therapy.

[170]  M. Hemler Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. , 2003, Annual review of cell and developmental biology.

[171]  Kristian Helin,et al.  EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer , 2003, The EMBO journal.

[172]  G. Dontu,et al.  Stem cells in normal breast development and breast cancer , 2003, Breast Cancer Research.

[173]  R. Jaenisch,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.

[174]  T. Illidge,et al.  RELEASE OF MITOTIC DESCENDANTS BY GIANT CELLS FROM IRRADIATED BURKITT'S LYMPHOMA CELL LINES , 2000, Cell biology international.

[175]  T. Illidge,et al.  POLYPLOID GIANT CELLS PROVIDE A SURVIVAL MECHANISM FOR p53 MUTANT CELLS AFTER DNA DAMAGE , 2000, Cell biology international.

[176]  P. Polakis Wnt signaling and cancer. , 2000, Genes & development.

[177]  J. Dick,et al.  Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.

[178]  E. Lazarides,et al.  Multinucleated cells can continuously generate mononucleated cells in the absence of mitosis: a study of cells of the avian osteoclast lineage. , 1995, Journal of cell science.

[179]  M. Caligiuri,et al.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.

[180]  J. Till,et al.  Cytological Demonstration of the Clonal Nature of Spleen Colonies Derived from Transplanted Mouse Marrow Cells , 1963, Nature.

[181]  D. Burk,et al.  On respiratory impairment in cancer cells. , 1956, Science.